Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Weiner

Showing results (51-60 of 1,343) with videos related to

Pageof 135
Sort By:
Cincinnati Journal of Medicine|March 19, 2010
Triweekly arsenotherapy a safe and effective ambulatory treatment regimen for early syphilisA L WEINER
The Journal of Pediatrics|June 1, 1979
"Nonpathogenic" Neisseria and meningitisR L Weiner
The New England Journal of Medicine|August 13, 1987
Cop 1 therapy for multiple sclerosisH L Weiner
Neurology|March 1, 1985
An assessment of plasma exchange in progressive multiple sclerosisH L Weiner
The American Journal of Managed Care|February 9, 2005
Correspondence regarding levalbuterol and racemic albuterol, July 2004 SupplementAlan L Weiner
Autoimmunity|January 1, 1993
Treatment of autoimmune diseases by oral tolerance to autoantigensH L Weiner
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Oral tolerance with copolymer 1 for the treatment of multiple sclerosisH L Weiner
Neurological Research|April 19, 2000
The future of peripheral nerve neurostimulationR L Weiner
Hospital Practice (1995)|September 15, 1995
Oral tolerance: mobilizing the gutH L Weiner
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 30, 1998
A 21 point unifying hypothesis on the etiology and treatment of multiple sclerosisH L Weiner
Pageof 135

Showing results (51-60 of 1,343) with videos related to

Sort By:
Pageof 135
Cincinnati Journal of Medicine|March 19, 2010
Triweekly arsenotherapy a safe and effective ambulatory treatment regimen for early syphilisA L WEINER
The Journal of Pediatrics|June 1, 1979
"Nonpathogenic" Neisseria and meningitisR L Weiner
The New England Journal of Medicine|August 13, 1987
Cop 1 therapy for multiple sclerosisH L Weiner
Neurology|March 1, 1985
An assessment of plasma exchange in progressive multiple sclerosisH L Weiner
The American Journal of Managed Care|February 9, 2005
Correspondence regarding levalbuterol and racemic albuterol, July 2004 SupplementAlan L Weiner
Autoimmunity|January 1, 1993
Treatment of autoimmune diseases by oral tolerance to autoantigensH L Weiner
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Oral tolerance with copolymer 1 for the treatment of multiple sclerosisH L Weiner
Neurological Research|April 19, 2000
The future of peripheral nerve neurostimulationR L Weiner
Hospital Practice (1995)|September 15, 1995
Oral tolerance: mobilizing the gutH L Weiner
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 30, 1998
A 21 point unifying hypothesis on the etiology and treatment of multiple sclerosisH L Weiner
Pageof 135